Odoardo Maria Olimpieri

A phase II study of <scp>G</scp>ivinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy

Guido Finazzi, Alessandro M. Vannucchi, Vincenzo Martinelli et al. · British Journal of Haematology · 2013 · 127 citations · Full text

A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment

Francesco Marchesi, Natalia Cenfra, Lidia Altomare et al. · Journal of Geriatric Oncology · 2013 · 40 citations

Retrospective Study, Lymphoid Neoplasia, Treatment Intensity +8

How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)

Massimo Breccia, Pier Paolo Olimpieri, Odoardo Maria Olimpieri et al. · Cancer Medicine · 2020 · 38 citations · Full text

Management of chronic myeloid leukaemia patients treated with ponatinib in a real‐life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)

Massimo Breccia, Pier Paolo Olimpieri, Simone Celant et al. · British Journal of Haematology · 2022 · 17 citations

A Phase II Study of the HDAC Inhibitor Givinostat In Combination with Hydroxyurea In Patients with Polycythemia Vera Resistant to Hydroxyurea Monotherapy

Alessandro Rambaldi, Guido Finazzi, Alessandro M. Vannucchi et al. · Blood · 2011 · 14 citations